Emery et al., Life Sci., vol. 33, No. 13, pp. 1285-1294, 1983. |
Litman et al., Biochim. Biophys. Acta, vol. 1361, No. 2, pp. 159-163, 1997. |
Besser et al., Nervenarzt, vol. 62, No. 12, pp. 760-761, 1991. |
Ngiam et al., Chem. Pharm. Bull., vol. 35, No. 1, pp. 409-412, 1987. |
Goodman-Gilman et al., The Pharmacological basis of therapeutics, Macmillan Publishing Co., New York, USA., pp. 125-127, 1987. |
Emery, C.E., et al., “Life Science, vol. 33. No. 13”, Arylmethanol and Thiosemiccarbazone Influence on Plasmodial Macromolecular Synthesis and Cell Stability, pp. 1285-1294, (Jul. 15, 1983). |
Litman, T. et al., “Biochemica et Biophysica Acta, vol. 1361”, Structure-activity relationships of P-glycoprotien interacting drugs: kinetic characterization of their effects on ATPase activity, pp. 159-168, (1997). |
Ngim, T.L., “Chem. Pharm. Bull., vol. 35 No. 1”,Sterospecific Inhibition of Cholinesterases by Mefloquine Enantiomers, pp. 409-412, (1987). |
Goodman-Gilman et al., “The Pharmacological Basis of Therapeutics”, MacMillan Publishing Company, New York, Therapeutic Uses of Anticholinesterase Drugs, XP002093901, pp. 125-127, (1987). |
Carrol, F.I. et al., “Journal of Medicinal Chemistry, vol. 17 No. 2”, Optical Isomers of Aryl-2-piperidylmenthanol Antimalarial Agents, Preparation, Optical Purity, and Absolute Sterochemistry, pp. 210-219, (1974). |
Thiesen, P.D., et al., “J. Org. Chem., 53”,Improved Procedure for Preparation of Optically Active 3-Hydroxyglutarate Monoesters and 3-Hydroxy-5-oxoalkanoic Acids, pp. 2374-2379, (1988). |
Shimada, Junichi et al., “Biooragnic & Medicinal Chemistry Letters, vol. 7 No. 18”, Adenosine A2AAntagonist with Potent Anti-Cataleptic Activity, pp. 2349-2353, (1997). |
Poucher, S.M., et al., “British Journal of Pharmacology, 115”, The in vitro Pharmacology of ZM 241385. a Potent, Non-XanthineA2A Selective Adenosine Receptor Antagonist, pp. 1096-1102, (1995). |
WHO Scientific Group, “The WHO Technical Report”, Pratical Chemotherapy of Malaria, pp. 1-145, (1990). |
Basco, L.K. “Br. J. Clin Pharmac. 33”, In vitro Activity of the Enantiomers of Mefloquin, Halofantrine and Enpiroline against Plasmodium Falciparum,pp. 517-520, (1990). |
Palmer, K.J., “Drugs 45(3)”Mefloquine: a Review of its Antimalarial Activity Pharmacokinetic Properties and Therapeutics Efficacypp. 430-475, (1993). |
Ohnmacht, C.J. et al., “Journal of Medicinal Chemistry vol. 14 No. 10”, Antimalarials. 7. Bis(trifluoromethyl)-a-(2-piperidyl)-4-quinolinemethanols1, pp. 926-929, (1971). |
“The Lancet” vol. 341, Anaesthesia Emergence Delirium After Melfoquine Propphlaxis, pp. 632-633 and pp. 326-327, (Mar. 6, 1993). |
Barrett, PJ et al., “BMJ vol. 313”, Comparison of Adverse Events Associates with uses of Mefloquine and Combination of Chloroquine and Proguanil as Antimalarial Prophylaxis: Postal and Telephone Survey of Travelers, pp. 525-528, (Aug. 31, 1996). |
“The Medical Journal of Australia, vol. 161”pp. 452 and 453, (Oct. 3, 1994). |
Sowunmi A., “Transaction of the Royal Society of Tropical Medicine and Hygiene, 87”, Neuropsychiatric Side Effects of Mefloquine in Africans, pp. 462-463, (1993). |
Hennequin, C. et al., “Arch Intern Med, vol. 154”, Severe Psychiatric Side Effects Observed During Prophylaxis and Treatment With Mefloquine, pp. 2360-2362, (Oct. 24, 1994). |
Speich, R. et al., “The New England Journal of Medicine, vol. 331 No. 1”, Central Anticholinergic Syndrome with the Antimalarial Drug Mefloquine, pp. 57-58 (Jul. 7, 1994). |
Ledent, C. et al., “Nature vol. 388”, Aggressiveness, Hypoalgesia and High Blood Pressure in Mice Lacking the Adenosine A2A Receptor, pp. 674-679, (Aug. 14, 1997). |
Knutsen, L.J.S. et al., “Adenosine and ATP in Epilepsy”, Adenosine and ATP in Epilipsy pp. 423-447 (1997). |
Jacobson, et al., “Purinocepetor and Agents and Antagonist”, Development of Selective Purinoceptor Agonist and Antagonist, pp. 101-128, (1987). |
Chu, N.S. et al., “Epilepsia, 22”, Caffine-and Aminophlline-Induced Seizures, pp. 85-95, (1981). |
Rudolph, K.A. et al., “Journal of Cerebral Blood Flow and Metabolism, 7”, Effect of Theophylline on Ischemically Induced Hippocampal Damage in Mongolian Gerbils: A Behavioral and Histopathological Study pp. 74-81, (1987). |
Pinder, R.M. et al., “Antimalarials. II”, Antimarials, II.1aa-(2-Piperidy)-and a-(2-Pyridyl)-2-trifluoromethly-4-quinolinemethanols1b, pp. 266-269, (Mar 1968). |
Hoffman-La Roche, “Tetrahedrom, vol. 47 No. 36”, A Straightforward and High Yielding Synthesis of Mefloquine-II, pp. 7609-7615, (1991). |
Karle , J.M., et al., Plasmodium falciparum: Role of Absolute Sterochemistry in the Antimalarial Activity of Synthetic Amino Alcohol Antimalarial Agents, pp. 345-351, (1993). |